Indian pharma sector set for steady growth in FY27 on domestic demand: Report
· thehindubusinessline.com
The Indian pharma sector anticipates steady growth in FY27, driven by domestic demand and expanding GLP-1 therapy opportunities.
The Indian pharmaceutical sector is expected to maintain a healthy growth trajectory in the coming quarters, supported by sustained domestic demand, a recovery ...